As monkeypox cases rise, HHS announces another 780,000 vaccines on Friday.

“Every American should pay attention to monkeypox,” HHS secretary Xavier Becerra told reporters during a phone call on Thursday. “It’s contagious, it’s painful, and it can be dangerous.”

But Becerra said he was not ready to declare a public health emergency, which would give the government a lot of new powers.

“We continue to monitor the reaction,” he said. “We will weigh any decision based on the response.”

Centers for Disease Control and Prevention who intend to make monkeypox condition requiring national notification, released new demographic data showing that 99 percent of cases are in people assigned male sex at birth, and most reported having had sex with men. Of the cases, which included data on race and ethnicity, 37 percent were in non-Hispanic white people, 31 percent in Hispanics or Latinos, 27 percent in non-Hispanic blacks or African Americans, and 4 percent in Asians.

The secretary said it is not inevitable that monkeypox will become endemic in the United States, even if officials expect the outbreak could spread beyond men who have sex with men.

“We can’t let this get out of control,” Becerra said. “Everyone has to do their part.”

Many more shots of Jynneos, a new-generation smallpox vaccine with limited global stocks, are on the way, with the US ordering 5.5 million additional doses to be filled and processed from existing bulk material. By May 2023, about 7 million doses are expected in the US.

It is not yet known how many people in the US received one of the vaccines.

The government will also have the option to order more than 11 million more doses of the vaccine, saying they hope to do so in the future. If doses are not used, they will be added to the smallpox preparedness program, Dawn O’Connell, who heads the Office of Strategic Preparedness and Response, told reporters Thursday.

While the U.S. has access to more vaccines than any other country, cities and states don’t have enough to keep up with demand. It also has a large supply of the older ACAM2000 vaccine, which may have more serious side effects and is not widely used for monkeypox in the US.

The World Health Organization said about 16 million doses of Jynneos vaccine are currently available worldwide, urging countries to share supplies.

Tecovirimat, an antiviral drug used to treat the virus, is also in the US arsenal. However, even with over 1 million doses in stock, it was difficult for suppliers to prescribe the drug, which led the FDA to update its usage policy.

To date, fewer than 10,000 people have received treatment.

Testing for the virus has also been stepped up, with a capacity of over 60,000 tests per week. Expanded testing — along with continued spread — means the number of cases will continue to rise, Becerra said.

“While this is a huge step forward in vaccine availability, we know more needs to be done,” O’Connell said.